SCHEMBL6166482

SCHEMBL6166482

CC(C)c1nn(C)c2c1C(=O)CC(C(C)C)C2

nearest known ligand 0.36

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164973 0.83 DHODH (0.36) DHODH
SCHEMBL6167029 0.83 CSNK2A2 (0.39)
SCHEMBL6163627 0.80 HTT (0.40) DHODH
SCHEMBL6164331 0.78 DHODH (0.34) DHODH
SCHEMBL21663039 0.75 PDE4B (0.31)
SCHEMBL6769804 0.74 PPARA (0.38) DHODH
SCHEMBL6163901 0.73 SMN1; SMN2 (0.46) DHODH
SCHEMBL6166619 0.72 HTT (0.42)
SCHEMBL6767259 0.72 SRC (0.40) DHODH
SCHEMBL6165262 0.72 CCNA2 (0.40) DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed